ATLANTA, March 10, 2010 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California against Medivation, Inc ("Medivation" or the "Company") (Nasdaq:MDVN) and certain of its officers. The complaint alleges, among other things, that Medivation violated federal securities laws by misrepresenting the effectiveness of its experimental drug Dimebon. According to the complaint, Medivation was forced to announce that Dimebon did not meet primary and secondary goals for Phase 3 trial.
Holzer Holzer & Fistel, LLC is currently investigating whether certain officers and directors of Medivation complied with the fiduciary duties they owed to the Company and its shareholders in connection with the conduct alleged in the class action lawsuit. If you have continuously owned Medivation common stock since at least July 2008 and are interested in learning more about your legal rights or if you have information that may be useful to our investigation, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.